YOLFTbeta
30

Shanxi C&Y Pharmaceutical Group Co Ltd

300254 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

7.42CNY-0.18 (-2.37%)

Price History

Full chart

Market Stats

Previous Close7.60
Open7.59
Day Range7.37 – 7.62
52-Week Range6.93 – 15.20
Volume5.93M
Market Cap2.36B
P/E (TTM)76.58
Forward P/E0.00
EPS0.12
Dividend Yield0.00%
Beta0.46
50-Day Avg8.65
200-Day Avg10.46

About

ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, smoking cessation drugs, pediatric drugs, respiratory system drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, nephropathy drugs, anti-depressants, medicines, pharmaceutical raw materials, and intermediates, commerce, etc. The company's product portfolio includes Fosfomycin tromethamine powder, Ebastine tablets, Tamsulosin hydrochloride sustained release capsules, Cinacalcet hydrochloride tablets, Apixaban tablets, Rivaroxaban tablets, Fluoxetine hydrochloride capsules, Ambroxol hydrochloride dispersible tablets, Montmorillonite powder, Varenicline tartrate tablets, Vitamin AD drops, and Baoling Yunbao oral liquid, as well as salt acid glucosamine raw material product. It also provides medical and health services and commercial services, such as medical diagnosis, gene preservation, and pregnancy environment testing services. The company was formerly known as Shanxi C&Y Pharmaceutical Co., Ltd. and changed its name to ShanXi C&Y Pharmaceutical Group Co.,LTD. in September 2014. The company was founded in 2005 and is based in Xuhui, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Qun Zhao
  • Employees1.16K
  • HeadquartersRoom 3605-3610, Xuhui, China, 200232, China
  • Websitehttps://www.cy-pharm.com

Leadership

  • Mr. Qun ZhaoPresident & Director · b. 1971
  • Mr. Yanjie HeFinancial Director · b. 1982
  • Mr. Ying Min YuChief Engineer · b. 1963
  • Mr. Junxian YuSecretary, VP & Non-Independent Director · b. 1967
  • Mr. Bao Ping GuVice President · b. 1972
  • Mr. Kai Rui LuoVice President · b. 1976
  • Ms. Han YinVice President · b. 1982
  • Ya Li LiuChief Accountant

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue203.67M203.67M243.62M319.55M310.78M361.50M513.51M653.66M683.93M746.08M938.93M1.14B1.13B848.07M930.37M829.00M799.31M846.61M870.79M
Growth (%)-0.00%+19.62%+31.17%-2.75%+16.32%+42.05%+27.29%+4.63%+9.09%+25.85%+21.04%-0.41%-25.07%+9.70%-10.90%-3.58%+5.92%+2.86%
Cost of Revenue125.85M125.85M142.86M174.86M165.54M143.92M183.72M206.65M218.40M252.94M290.10M268.31M278.56M264.55M290.06M251.21M259.45M283.21M284.04M
Gross Profit77.81M77.81M100.76M144.69M145.24M217.58M329.79M447.00M465.53M493.14M648.83M868.19M853.24M583.52M640.32M577.79M539.86M563.39M586.75M
Gross Margin38.21%38.21%41.36%45.28%46.73%60.19%64.22%68.39%68.07%66.10%69.10%76.39%75.39%68.81%68.82%69.70%67.54%66.55%67.38%
Operating Expense63.71M63.71M62.68M96.70M104.29M192.47M284.51M395.36M434.67M469.08M620.01M882.99M894.36M898.63M719.89M692.88M499.70M498.40M471.40M
Operating Income14.10M14.10M38.08M47.99M40.96M25.11M45.28M51.65M30.87M24.06M28.82M-14.80M-41.12M-315.11M-79.57M-115.09M40.15M64.99M115.35M
Operating Margin6.92%6.92%15.63%15.02%13.18%6.95%8.82%7.90%4.51%3.23%3.07%-1.30%-3.63%-37.16%-8.55%-13.88%5.02%7.68%13.25%
EBITDA20.57M27.77M56.48M69.48M61.14M67.43M72.42M103.62M90.52M106.95M106.62M84.86M72.58M-178.89M47.41M14.34M141.17M148.63M171.79M
EBITDA Margin10.10%13.63%23.19%21.74%19.67%18.65%14.10%15.85%13.24%14.33%11.36%7.47%6.41%-21.09%5.10%1.73%17.66%17.56%19.73%
Net Income13.04M13.04M28.90M47.98M35.34M25.80M27.11M41.00M22.90M30.15M21.67M7.24M5.30M-262.37M-91.44M-118.52M25.20M42.19M24.85M
Net Income Margin6.40%6.40%11.86%15.02%11.37%7.14%5.28%6.27%3.35%4.04%2.31%0.64%0.47%-30.94%-9.83%-14.30%3.15%4.98%2.85%
R&D-----16.16M20.19M27.42M31.42M34.63M43.44M53.54M48.95M72.39M57.12M54.52M49.97M56.53M50.80M
R&D as % of Total Revenue-----4.47%3.93%4.20%4.59%4.64%4.63%4.71%4.33%8.54%6.14%6.58%6.25%6.68%5.83%
Interest Expense4.04M4.06M5.80M4.87M4.04M5.55M4.11M6.64M9.41M14.45M15.84M13.98M18.42M55.08M49.17M46.06M33.29M17.11M21.63M
Interest Expense % of Total Revenue1.98%1.99%2.38%1.52%1.30%1.54%0.80%1.02%1.38%1.94%1.69%1.23%1.63%6.49%5.29%5.56%4.17%2.02%2.48%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-224.15M259.51M280.84M702.56M827.16M1.09B1.18B1.31B1.43B1.52B1.50B1.80B1.80B1.53B1.58B1.43B1.55B1.64B
Total Liabilities-117.45M141.91M131.25M121.39M175.99M323.21M358.17M435.93M477.74M547.42M564.47M869.43M927.91M782.23M854.64M654.64M949.55M1.05B
Total Equity-106.70M117.60M149.59M581.17M596.27M610.00M637.62M786.00M808.66M819.59M799.09M815.89M687.10M589.41M574.92M600.13M343.00M304.62M
Cash-6.25M95.72M80.51M395.10M300.06M108.47M134.31M217.96M158.25M151.50M147.69M143.35M188.44M107.26M263.95M132.00M149.52M161.32M
Total Debt-40.00M60.00M60.00M40.00M77.50M143.00M130.00M182.00M248.00M240.20M287.80M353.21M335.09M229.59M603.44M226.22M311.56M-
Net Debt-33.75M-35.72M-20.51M-355.10M-222.56M34.53M-4.31M-35.96M89.75M88.70M140.11M209.86M146.66M122.33M339.50M94.21M162.05M170.09M

Cash Flow

Currency: CNY2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-39.16M105.55M52.03M4.75M35.05M80.58M82.19M15.44M41.65M40.10M38.44M69.63M-20.88M96.92M74.88M37.81M70.94M96.77M
Investing Cash Flow51.75M-12.33M-46.33M-66.03M-148.90M-274.26M-30.49M-158.88M-155.76M-4.39M-23.16M-349.11M-5.41M-25.21M-23.20M72.10M-248.27M-
Financing Cash Flow-7.97M-3.76M-20.91M373.37M21.31M2.08M-25.86M225.01M56.42M-45.44M-16.21M275.02M63.33M-152.30M112.56M-241.77M194.84M-
Capital Expenditure882.30K12.33M47.78M66.03M45.38M57.91M34.20M35.68M50.78M101.07M29.59M18.54M31.46M36.93M26.78M33.92M51.50M34.32M
Free Cash Flow-40.04M93.22M4.26M-61.28M-10.33M22.67M47.99M-20.24M-9.13M-60.97M8.85M51.09M-52.34M59.99M48.09M3.90M19.44M62.45M
Dividends Paid4.07M23.76M20.91M4.08M16.19M17.42M20.06M22.40M22.48M24.81M35.92M4.17M20.82M14.67M11.90M13.31M12.32M18.97M
FCF to OCF102.25%88.32%8.18%-1290.14%-29.46%28.13%58.39%-131.07%-21.92%-152.02%23.03%73.37%250.69%61.90%64.23%10.31%27.40%64.54%
Dividend Paid to FCF-10.16%25.48%491.35%-6.65%-156.75%76.82%41.80%-110.65%-246.19%-40.70%405.85%8.15%-39.78%24.46%24.75%341.54%63.38%30.37%

Earnings

Report DateSep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 22, 2016Sep 30, 2016Mar 3, 2017Apr 25, 2017Aug 11, 2017Oct 27, 2017Dec 31, 2017Apr 26, 2018Aug 29, 2018Oct 26, 2018Dec 31, 2018Apr 26, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 28, 2020Aug 27, 2020Oct 29, 2020Dec 31, 2020Apr 27, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 18, 2024Jun 3, 2024Jun 30, 2024Oct 23, 2024Dec 31, 2024Apr 18, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------
EPS Actual0.040.020.030.040.020.050.030.040.040.040.040.070.060.050.040.060.06-0.040.030.060.040.010.030.070.01-0.010.040.050.02-0.070.100.110.01-0.18-0.21-0.15-0.23-0.610.00-0.02-0.01-0.38-0.01-0.09-0.01-0.39-0.01-0.090.040.160.080.060.04-0.010.04-0.040.090.010.010.00
Surprise------------------------------------------------------------
Timing-------------------After-hours-After-hoursPre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-market-Pre-market------------------Pre-marketAfter-hours-Pre-market-Pre-market-----

Key Statistics & Ratios

Market Cap2.36B
Enterprise Value2.73B
Trailing P/E76.58
Forward P/E0.00
PEG Ratio0.00
Price / Sales2.78
Price / Book5.14
EPS0.12
Book Value1.75
Revenue (TTM)849.67M
Gross Profit (TTM)560.24M
EBITDA149.54M
Profit Margin3.38%
Operating Margin7.59%
Return on Equity9.85%
Return on Assets4.05%
Shares Outstanding257.21M
Shares Float216.63M
Beta0.46
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20191×
0.02Jul 11, 2019
20181×
0.05Jul 6, 2018
20171×
0.05Jun 23, 2017
20161×
0.05Jul 8, 2016
20151×
0.07Jun 15, 2015
20141×
0.07May 27, 2014
20131×
0.07Jul 5, 2013
20121×
0.06May 25, 2012

Stock Splits

  • Jul 8, 201612:10
  • Jun 15, 201512:10